Abstract

Objective: Urinary tract infections (UTIs) are among the most common serious bacterial infections in early childhood and are associated with significant morbidity, particularly in children under 36 months of age. This study aimed to evaluate the clinical and laboratory characteristics of children aged 1–36 months diagnosed with UTI, determine the frequency of accompanying urinary system anomalies, and assess the role of inflammatory markers in differentiating upper and lower UTIs.

Materials and Methods: This retrospective study included 260 children aged 1–36 months diagnosed with UTI between September 2022 and April 2023. Demographic, clinical, laboratory, and imaging data were analyzed. Patients were classified as having upper or lower UTI based on clinical and laboratory findings.

Results: The mean age of the sample was 8.22±7.38 months. Of the 260 patients (136 males and 124 females), 60.4% had lower UTI and 39.6% had upper UTI. Urinary system anomalies were detected in 20% of patients and were significantly more frequent in those with upper UTI (p=0.040). The most common pathogen was Escherichia coli (78.8%). Inflammatory markers including IG percentage, CRP, SII, ANC, and white blood cell count were significantly higher in the upper UTI group (p<0.001, p<0.001, p=0.003, p<0.001 and p<0.001, respectively). ROC analysis demonstrated that CRP (AUC: 0.74), IG percentage (AUC: 0.73), ANC (AUC: 0.72), and SII (AUC: 0.71) had moderate diagnostic performance in predicting upper UTI. IG percentage and SII showed relatively high sensitivity and specificity at optimal cut-off values.

Conclusion:  Urinary system anomalies are more common in children with upper UTI and should be carefully investigated in this group. Inflammatory markers, particularly IG percentage and SII, may serve as useful, easily accessible biomarkers in differentiating upper from lower UTI in early childhood. Their combined use with clinical findings may improve early diagnosis and management.

References

  1. Wald ER. Urinary tract infections in infants and children: a comprehensive overview. Curr Opin Pediatr. 2004;16(1):85-8. https://doi.org/10.1097/00008480-200402000-00016
  2. Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J. 2008;27(4):302-8. https://doi.org/10.1097/INF.0b013e31815e4122
  3. Yosypiv IV. Congenital anomalies of the kidney and urinary tract: a genetic disorder. Int J Nephrol. 2012;2012:909083. https://doi.org/10.1155/2012/909083
  4. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003;348(2):101-8. https://doi.org/10.1056/NEJMoa020549
  5. García EH, Olavarría F, Araya C, Broussain M, Barrera C, Young L. Diagnostic significance of clinical and laboratory findings to localize the site of urinary infection. Pediatr Nephrol. 2007;22(7):1002-6. https://doi.org/10.1007/s00467-007-0465-7
  6. Gervaix A, Galetto-Lacour A, Gueron T, Vadas L, Zamora S, Suter S, et al. Usefulness of procalcitonin and C-reactive protein rapid tests in children with urinary tract infection. Pediatr Infect Dis J. 2001;20(5):507-11. https://doi.org/10.1097/00006454-200105000-00007
  7. Karakaya D, Güngör T, Cakıcı EK, Yazılıtaş F, Çelikkaya E, Bülbül M. Determining the effectiveness of the immature granulocyte percentage and systemic immune-inflammation index in predicting acute pyelonephritis. Postgrad Med. 2023;135(2):155-60. https://doi.org/10.1080/00325481.2022.2152970
  8. Schwartz GJ, Muñoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629-37. https://doi.org/10.1681/ASN.2008030287
  9. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137-47. https://doi.org/10.7326/0003-4819-139-2-200307150-00013
  10. Roberts KB; Subcommittee on Urinary Tract Infection. Urinary tract infection: clinical practice guideline for febrile infants and children 2-24 months. Pediatrics. 2011;128(3):595-610. https://doi.org/10.1542/peds.2011-1330
  11. de Bessa J Jr, de Carvalho Mrad FC, Mendes EF, et al. Antibiotic prophylaxis for prevention of febrile urinary tract infections in children with vesicoureteral reflux. J Urol. 2015;193(5 Suppl):1772-7. https://doi.org/10.1016/j.juro.2014.10.092
  12. Stein R, Dogan HS, Hoebeke P, Kočvara R, Nijman RJ, Radmayr C, Tekgül S. Urinary tract infections in children: EAU/ESPU guidelines. Eur Urol. 2015;67(3):546-58. https://doi.org/10.1016/j.eururo.2014.11.007
  13. Becknell B, Schober M, Korbel L, Spencer JD. Diagnosis and management of pediatric urinary tract infections. Expert Rev Anti Infect Ther. 2015;13(1):81-90. https://doi.org/10.1586/14787210.2015.986097
  14. Mishra OP, Abhinay A, Prasad R. Urinary infections in children. Indian J Pediatr. 2013;80(10):838-43. https://doi.org/10.1007/s12098-013-1118-4
  15. Zorc JJ, Kiddoo DA, Shaw KN. Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev. 2005;18(2):417-22. https://doi.org/10.1128/CMR.18.2.417-422.2005
  16. Mattoo TK, Shaikh N, Nelson CP. Contemporary management of urinary tract infection in children. Pediatrics. 2021;147(2):e2020012138. https://doi.org/10.1542/peds.2020-012138
  17. Brandström P, Hansson S. Urinary tract infection in children. Pediatr Clin North Am. 2022;69(6):1099-114. https://doi.org/10.1016/j.pcl.2022.07.003
  18. Uyar Aksu N, Ekinci Z, Dündar D, Baydemir C. Childhood urinary tract infection caused by ESBL-producing bacteria: risk factors and empiric therapy. Pediatr Int. 2017;59(2):176-80. https://doi.org/10.1111/ped.13112
  19. Ammenti A, Cataldi L, Chimenz R, et al. Febrile urinary tract infections in young children: recommendations. Acta Paediatr. 2012;101(5):451-7. https://doi.org/10.1111/j.1651-2227.2011.02549.x
  20. Murugapoopathy V, Gupta IR. Congenital anomalies of the kidneys and urinary tract (CAKUT). Clin J Am Soc Nephrol. 2020;15(5):723-31. https://doi.org/10.2215/CJN.12581019
  21. Stonebrook E, Hoff M, Spencer JD. Congenital anomalies of the kidney and urinary tract: a clinical review. Curr Treat Options Pediatr. 2019;5(3):223-35. https://doi.org/10.1007/s40746-019-00166-3
  22. Kohno M, Ogawa T, Kojima Y, et al. Pediatric congenital hydronephrosis. Int J Urol. 2020;27(5):369-76. https://doi.org/10.1111/iju.14207
  23. Delbet JD, Lorrot M, Ulinski T. Antibiotic prophylaxis and treatment for urinary tract infections in children. Expert Opin Pharmacother. 2017;18(15):1619-25. https://doi.org/10.1080/14656566.2017.1383383
  24. Okarska-Napierała M, Wasilewska A, Kuchar E. Urinary tract infection in children: comparison of guidelines. J Pediatr Urol. 2017;13(6):567-73. https://doi.org/10.1016/j.jpurol.2017.07.018

How to cite

1.
Demirel C, Çelikkaya E, Güngör T. Urinary system anomalies and inflammatory markers in children aged 1–36 months with urinary tract infection. Turk J Pediatr Dis. 2026;Early View:1-7. https://doi.org/10.12956/TJPD.2026.1367